Literature DB >> 9692559

Metachronous colorectal cancers.

O Fajobi1, C Y Yiu, S B Sen-Gupta, P B Boulos.   

Abstract

BACKGROUND: Up to 9 per cent of patients who undergo resection for colorectal cancer develop metachronous cancers. There is no consensus on the detection and management of such cancers.
METHODS: The literature was reviewed exhaustively regarding the incidence, clinical characteristics, detection, treatment and molecular genetics of metachronous colorectal cancers. This was based on a Medline search from 1966 to December 1997 for articles on metachronous colorectal cancers. A manual search was also performed on references quoted in these articles. All publications relevant to this study were included.
RESULTS: Although the underlying causes for metachronous colorectal cancers are yet to be elucidated, risk factors for the disease have been identified. These include the presence of synchronous polyps or cancers, a history of metachronous cancers, and hereditary non-polyposis colorectal cancer (HNPCC).
CONCLUSION: Preoperative colonoscopy and postoperative colonoscopic surveillance are essential in identifying patients at risk of metachronous colorectal cancer. A total colectomy and ileorectal anastomosis should be considered for some patients, certainly for those with HNPCC.

Entities:  

Mesh:

Year:  1998        PMID: 9692559     DOI: 10.1046/j.1365-2168.1998.00800.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

1.  Laparoscopic salvage surgery for recurrent and metachronous colorectal cancer: 15 years' experience in a single center.

Authors:  Soo Yeun Park; Gyu-Seog Choi; Soo Han Jun; Jun-Seok Park; Hye Jin Kim
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

2.  Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.

Authors:  Fatih Safa Erenay; Oguzhan Alagoz; Ritesh Banerjee; Adnan Said; Robert R Cima
Journal:  Cancer       Date:  2016-06-01       Impact factor: 6.860

3.  Polyp surveillance after surgery for colorectal cancer.

Authors:  Kazushige Kawai; Eiji Sunami; Nelson H Tsuno; Joji Kitayama; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2012-02-03       Impact factor: 2.571

4.  Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?

Authors:  Morgan Anyla; Jérémie H Lefevre; Ben Creavin; Chrystelle Colas; Magali Svrcek; Olivier Lascols; Clotilde Debove; Najim Chafai; Emmanuel Tiret; Yann Parc
Journal:  Int J Colorectal Dis       Date:  2018-03-12       Impact factor: 2.571

Review 5.  Multiple primary colorectal cancer: Individual or familial predisposition?

Authors:  José A Pajares; José Perea
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

6.  Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation.

Authors:  Fatih Safa Erenay; Oguzhan Alagoz; Ritesh Banerjee; Robert R Cima
Journal:  Med Decis Making       Date:  2011-01-06       Impact factor: 2.583

Review 7.  Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.

Authors:  Peter R Holt; Peter Kozuch; Seetal Mewar
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

8.  Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance.

Authors:  Yuan-Tzu Lan; Jen-Kou Lin; Anna Fen-Yau Li; Tzu-Chen Lin; Wei-Shone Chen; Jeng-Kae Jiang; Shung-Haur Yang; Huann-Sheng Wang; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2004-09-02       Impact factor: 2.571

9.  Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma.

Authors:  Hong-Zhi Wang; Xin-Fu Huang; Yi Wang; Jia-Fu Ji; Jin Gu
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

10.  Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.

Authors:  Harindra Jayasekara; Jeanette C Reece; Daniel D Buchanan; Christophe Rosty; S Ghazaleh Dashti; Driss Ait Ouakrim; Ingrid M Winship; Finlay A Macrae; Alex Boussioutas; Graham G Giles; Dennis J Ahnen; Jan Lowery; Graham Casey; Robert W Haile; Steven Gallinger; Loic Le Marchand; Polly A Newcomb; Noralane M Lindor; John L Hopper; Susan Parry; Mark A Jenkins; Aung Ko Win
Journal:  Int J Cancer       Date:  2016-05-09       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.